DK158585D0 - Fremgangsmaade til fremstilling af streptococcus-m-protein-immunogener og molekylarsonder - Google Patents

Fremgangsmaade til fremstilling af streptococcus-m-protein-immunogener og molekylarsonder

Info

Publication number
DK158585D0
DK158585D0 DK158585A DK158585A DK158585D0 DK 158585 D0 DK158585 D0 DK 158585D0 DK 158585 A DK158585 A DK 158585A DK 158585 A DK158585 A DK 158585A DK 158585 D0 DK158585 D0 DK 158585D0
Authority
DK
Denmark
Prior art keywords
suns
streptococcus
molecular
procedure
preparation
Prior art date
Application number
DK158585A
Other languages
English (en)
Other versions
DK158585A (da
Inventor
June R Scott
Vincent A Fischetti
Original Assignee
Univ Rockefeller
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller, Univ Emory filed Critical Univ Rockefeller
Publication of DK158585A publication Critical patent/DK158585A/da
Publication of DK158585D0 publication Critical patent/DK158585D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK158585A 1983-08-10 1985-04-09 Fremgangsmaade til fremstilling af streptococcus-m-protein-immunogener og molekylarsonder DK158585D0 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52196283A 1983-08-10 1983-08-10
US06/621,716 US4784948A (en) 1983-08-10 1984-06-18 Production of streptococcal m protein immunogens and molecular probes
PCT/US1984/001261 WO1985000832A1 (en) 1983-08-10 1984-08-09 Production of streptococal m protein immunogens and molecular probes

Publications (2)

Publication Number Publication Date
DK158585A DK158585A (da) 1985-04-09
DK158585D0 true DK158585D0 (da) 1985-04-09

Family

ID=27060649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK158585A DK158585D0 (da) 1983-08-10 1985-04-09 Fremgangsmaade til fremstilling af streptococcus-m-protein-immunogener og molekylarsonder

Country Status (8)

Country Link
US (2) US4784948A (da)
EP (1) EP0152468B1 (da)
JP (2) JP2926180B2 (da)
AU (1) AU574385B2 (da)
CA (1) CA1339266C (da)
DE (1) DE3485267D1 (da)
DK (1) DK158585D0 (da)
WO (1) WO1985000832A1 (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678702D1 (de) * 1985-12-28 1991-05-16 Ohgen Research Lab Ltd Antitumorprotein-gen von streptococcus pyogenes su, plasmide, die das gen enthalten, transformantenzellen, die die plasmide beherbergen, und verfahren zur herstellung des antitumorproteins.
WO1988002781A1 (en) * 1986-10-08 1988-04-21 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci
EP0290707B1 (en) * 1987-05-13 1992-07-22 HighTech Receptor AB An immunoglobulin a receptor protein (arp), cloning and expression thereof
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5162226A (en) * 1987-08-24 1992-11-10 University Of Tennessee Research Corp. (U.T.R.C.) Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US6602507B1 (en) * 1988-03-25 2003-08-05 The Rockefeller University Synthetic peptides from streptococcal M protein and vaccines prepared therefrom
AU5948490A (en) * 1989-06-21 1991-01-08 Rockefeller University, The Recombinant poxvirus and streptococcal m protein vaccine
US5616686A (en) * 1990-05-11 1997-04-01 The Rockefeller University Polypeptide of a hybrid surface protein by bacteria
US5476929A (en) * 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
US5232831A (en) * 1991-06-28 1993-08-03 Gen-Probe Incorporated Nucleic acid probes to streptococcus pyogenes
EP0618813B1 (en) * 1992-09-16 2002-01-09 The University Of Tennessee Research Corporation Antigen of hybrid m protein and carrier for group a streptococcal vaccine
IL107025A0 (en) * 1992-09-16 1993-12-28 Univ Tennessee Res Corp Recombinant multivalent m protein vaccine
AU4932493A (en) * 1992-09-25 1994-04-26 Dynagen, Inc. An immunobooster for delayed release of immunogen
EP1538208A3 (en) 1995-06-07 2007-05-23 Regents Of The University Of Minnesota Mutants of streptococcal toxin A and methods of use
DE19535321A1 (de) * 1995-09-22 1997-03-27 Max Planck Gesellschaft Neues Adhäsin aus Helicobacter pylori
US20020136739A1 (en) * 1996-07-12 2002-09-26 Cates George A. Subunit respiratory syncytial virus preparation
US5882896A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
CN1211487C (zh) 1996-12-06 2005-07-20 明尼苏达大学董事会 链球菌毒素a突变体及其使用方法
CN1148449C (zh) 1996-12-06 2004-05-05 明尼苏达大学董事会 链球菌毒素c突变体及其使用方法
US6774218B2 (en) 1996-12-06 2004-08-10 Regents Of The University Of Minnesota Mutants of streptococcal toxin C and methods of use
US6716433B1 (en) * 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
US20020136712A1 (en) * 1997-10-31 2002-09-26 Fischetti Vincent Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6406692B1 (en) * 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US20030129147A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US20030082110A1 (en) * 1997-10-31 2003-05-01 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
US7063837B2 (en) * 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
RU2240327C2 (ru) * 1999-12-23 2004-11-20 Вмакс Лимитед Ген и белок вирулентности и их использование
US20070128229A1 (en) * 2002-04-12 2007-06-07 Wyeth Surface proteins of Streptococcus pyogenes
JP2004533236A (ja) * 2001-04-13 2004-11-04 ワイエス 化膿性連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｙｏｇｅｎｅｓ）の表面タンパク質
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
CA2463008A1 (en) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Efficient protein expression system
CN107050442B (zh) * 2008-11-05 2022-09-13 惠氏有限责任公司 用于预防β-溶血链球菌(BHS)疾病的多组分免疫原性组合物
US20210102876A1 (en) * 2017-03-02 2021-04-08 Hero Scientific Ltd. Testing for particulates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284537A (en) * 1980-07-03 1981-08-18 The United States Of America As Represented By The Department Of Health And Human Services Conjugate of streptococcal M protein peptide vaccine
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes

Also Published As

Publication number Publication date
AU574385B2 (en) 1988-07-07
EP0152468B1 (en) 1991-11-13
DK158585A (da) 1985-04-09
JP2926180B2 (ja) 1999-07-28
JPS60501689A (ja) 1985-10-11
CA1339266C (en) 1997-08-12
WO1985000832A1 (en) 1985-02-28
EP0152468A4 (en) 1987-03-12
AU3316184A (en) 1985-03-12
US5840314A (en) 1998-11-24
EP0152468A1 (en) 1985-08-28
JPH06233693A (ja) 1994-08-23
DE3485267D1 (de) 1991-12-19
US4784948A (en) 1988-11-15
JP2614176B2 (ja) 1997-05-28

Similar Documents

Publication Publication Date Title
DK158585A (da) Fremgangsmaade til fremstilling af streptococcus-m-protein-immunogener og molekylarsonder
DK497682A (da) Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge
DK606084A (da) Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol
DK362483A (da) Varmeisoleret ledningsroer og fremgangsmaade til fremstilling af samme
DK559387D0 (da) Fremgangsmaade og mellemprodukt til fremstilling af 3-pyrrolidinoler
DK386784D0 (da) Fremgangsmaade til fremstilling af alfa-6-desoxy-tetracykliner
DK240484D0 (da) Sejl og fremgangsmaade til fremstilling af samme
DK155984A (da) Fremgangsmaade til fremstilling af thiadiazolderivater
DK315481A (da) Anilinderivater og fremgangsmaade til fremstilling af samme
DK530181A (da) Heme-koncentrat og fremgangsmaade til fremstilling af samme
DK549087A (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK140584A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK28883A (da) Dentalkonstruktion og fremgangsmaade til fremstilling af samme
DK593283D0 (da) Mikroporoes krystallinsk ferrosilicat og fremgangsmade til fremstilling af samme
DK381984A (da) Fremgangsmaade til fremstilling af aspartam
DK287484D0 (da) Fremgangsmaade til fremstilling af acetaldehyd
DK37890D0 (da) Fremgangsmaade til fremstilling af 6-deoxyanthracycliner
DK423284A (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK440281A (da) Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf
DK175290D0 (da) Fremgangsmaade til fremstilling af azetidinoner
DK162475C (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin og fremgangsmaade til fremstiling af praeparatet
DK157874C (da) Fremgangsmaade til fremstilling af azinomethylrifamyciner
DK290682A (da) Fremgangsmaade til fremstilling af 24-cyclopropylcholen-3beta,22-dioler og estere deraf
DK573184D0 (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK246687A (da) Fremgangsmaade til fremstilling af mikroorganismelipase og til foroegelse af dennes maalelige aktivitet

Legal Events

Date Code Title Description
PUP Patent expired